Medically Supervised Benzodiazepine Detox Across New York

Brooklyn leads with 10 programs. New York and Bronx also run inpatient benzo detox and dual-diagnosis units, and Brooklyn, New York, Bronx, and Buffalo each keep at least one option available for the acute stabilization phase before the long outpatient taper.

The inpatient stabilization window in New York typically runs 7-14 days, but the taper itself stretches well beyond that — weeks to months in outpatient is the norm, with Ashton Manual-style reductions of 5-10% every 2-4 weeks. The shape of the taper is driven by dose, duration of use, half-life of the original agent, and how the underlying anxiety responds as the medication comes down. Long-term high-dose users frequently need a six-month-plus taper to keep symptoms manageable.

Yes. New York carries a mix of sliding-scale, grant-funded, and state-funded options among the 62 programs listed here, and SAMHSA's 1-800-662-HELP line routes callers to no-cost crisis admissions when the need is acute. Community-based nonprofits — Hudson Mohawk Recovery among them — have historically held aside slots for uninsured neighbors, including the longer cross-tapers that other settings sometimes shy away from.

The protocol cross-titrates from short-acting agents (Xanax/alprazolam, Ativan/lorazepam) onto a long half-life benzodiazepine — usually diazepam (Valium), sometimes clonazepam (Klonopin) — and then steps that anchor down slowly under medical supervision. Adjunct medications layer in around the spine: anticonvulsants like gabapentin or pregabalin to soften withdrawal and lower seizure risk, beta-blockers (propranolol) for autonomic symptoms and tremor, trazodone or hydroxyzine for sleep, and SSRIs or buspirone to begin addressing the underlying anxiety. Flumazenil is contraindicated as a reversal agent in long-term users — it can precipitate seizures.

No. The inpatient stay handles the seizure window and the cross-titration, but the slow taper of the long-acting anchor — the actual work of getting off the medication — continues for weeks or months. Strong New York programs build the rest of the continuum (outpatient taper management, CBT for anxiety, mutual-aid groups for prescription dependence, family work) into the discharge plan rather than treating the inpatient stay as a destination. PAWS can surface weeks after the last dose change, and continuity of care is what gets people through it.

It can be, particularly for anyone on a long-term daily benzodiazepine. Abrupt or even moderately fast reductions can trigger grand mal seizures, severe rebound anxiety, and protracted withdrawal symptoms that last months. A slow physician-managed outpatient taper can work safely for milder presentations with stable households and good continuity of care. Whenever there is genuine doubt — high dose, polypharmacy, prior seizure history, severe untreated anxiety — inpatient stabilization first is the safer choice.